At this time, it is unknown whether Exforge HCT (amlodipine-valsartan-hydrochlorothiazide) is safe for nursing women or their infants. One component of the drug is known to pass through breast milk, but low doses do not appear to cause any problems for nursing infants. Breastfeeding women should consult their healthcare providers before taking Exforge HCT.
Hydrochlorothiazide passes through breast milk, although doses below 50 mg per day are not thought to cause any problems (this is higher than the highest strength of hydrochlorothiazide in Exforge HCT). Higher doses may suppress breast milk production.
No research has been done to see if the other two active ingredients in Exforge HCT pass through breast milk. The manufacturer of Exforge HCT warns against taking this medication while breastfeeding.
Talking With Your Healthcare Provider About Breastfeeding and Exforge HCT
You should talk with your healthcare provider about taking this drug while breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click